Header Logo

JEFFREY SHERER

Concepts (93)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antipsychotic Agents
6
2020
390
0.570
 Why?
Bipolar Disorder
4
2019
367
0.390
 Why?
Cholinesterase Inhibitors
3
2022
103
0.380
 Why?
Dementia
4
2021
489
0.360
 Why?
Drug Prescriptions
3
2019
244
0.350
 Why?
Nursing Homes
3
2019
107
0.300
 Why?
Antidepressive Agents
3
2017
327
0.290
 Why?
Psychotropic Drugs
2
2019
130
0.270
 Why?
Diphosphonates
1
2007
43
0.260
 Why?
Refuse Disposal
1
2006
6
0.250
 Why?
Pneumonia
2
2020
341
0.250
 Why?
Imidazoles
1
2007
218
0.240
 Why?
Environmental Pollutants
1
2006
80
0.230
 Why?
Environmental Exposure
1
2006
236
0.210
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2006
288
0.200
 Why?
Parkinson Disease
2
2020
740
0.190
 Why?
Bone Neoplasms
1
2007
447
0.190
 Why?
Urinary Bladder, Overactive
1
2021
32
0.180
 Why?
Weight Gain
2
2019
412
0.150
 Why?
Depression
3
2020
1366
0.150
 Why?
Prostatic Neoplasms
1
2007
1606
0.140
 Why?
Atomoxetine Hydrochloride
1
2017
15
0.130
 Why?
Child Psychiatry
1
2017
16
0.130
 Why?
Adrenergic Uptake Inhibitors
1
2017
29
0.130
 Why?
United States
11
2022
11726
0.130
 Why?
Central Nervous System Stimulants
1
2017
131
0.120
 Why?
Physicians, Primary Care
1
2017
99
0.120
 Why?
Nebulizers and Vaporizers
1
2015
59
0.120
 Why?
Alzheimer Disease
1
2022
882
0.110
 Why?
Body Mass Index
2
2019
1713
0.110
 Why?
Attention Deficit Disorder with Hyperactivity
1
2017
238
0.110
 Why?
Medicare
3
2022
468
0.100
 Why?
Aged
10
2022
21502
0.100
 Why?
Retrospective Studies
9
2022
17567
0.100
 Why?
Galantamine
2
2022
11
0.100
 Why?
Rivastigmine
2
2022
18
0.100
 Why?
Cohort Studies
4
2022
5199
0.090
 Why?
Medication Adherence
1
2015
343
0.090
 Why?
Patient Readmission
1
2015
430
0.090
 Why?
Muscarinic Antagonists
2
2021
38
0.090
 Why?
Patient Discharge
1
2015
521
0.090
 Why?
Homes for the Aged
1
2010
26
0.090
 Why?
Activities of Daily Living
2
2010
432
0.090
 Why?
Practice Patterns, Physicians'
1
2017
772
0.080
 Why?
Cholinergic Antagonists
1
2010
54
0.080
 Why?
Aged, 80 and over
5
2020
7142
0.080
 Why?
Male
15
2022
65596
0.080
 Why?
Computers, Handheld
1
2009
33
0.080
 Why?
Drug Utilization Review
1
2009
33
0.080
 Why?
Pharmacists
1
2009
104
0.070
 Why?
Pulmonary Disease, Chronic Obstructive
1
2015
631
0.070
 Why?
Health Care Surveys
1
2009
295
0.070
 Why?
Female
14
2022
71507
0.070
 Why?
Humans
17
2022
133383
0.070
 Why?
United States Environmental Protection Agency
1
2006
8
0.060
 Why?
United States Food and Drug Administration
1
2006
158
0.060
 Why?
Pharmaceutical Preparations
1
2006
91
0.060
 Why?
Comorbidity
2
2020
1622
0.060
 Why?
Adolescent
6
2019
20574
0.050
 Why?
Phenylcarbamates
1
2022
16
0.050
 Why?
Indans
1
2022
56
0.050
 Why?
Medicaid
2
2014
254
0.040
 Why?
Acetylcholinesterase
1
2021
26
0.040
 Why?
Child
6
2019
25869
0.040
 Why?
Piperidines
1
2022
241
0.040
 Why?
Withholding Treatment
1
2019
69
0.040
 Why?
Cross-Sectional Studies
3
2010
3740
0.030
 Why?
Antineoplastic Agents
1
2007
1849
0.030
 Why?
Body Weight
1
2019
1035
0.030
 Why?
Middle Aged
3
2015
28987
0.030
 Why?
Bronchodilator Agents
1
2015
153
0.030
 Why?
Risk
1
2014
782
0.020
 Why?
Incidence
1
2019
3396
0.020
 Why?
Treatment Outcome
1
2007
13103
0.020
 Why?
Proportional Hazards Models
1
2014
1473
0.020
 Why?
Social Class
1
2010
207
0.020
 Why?
Prescriptions
1
2009
42
0.020
 Why?
Interviews as Topic
1
2010
427
0.020
 Why?
Social Behavior
1
2010
230
0.020
 Why?
Data Collection
1
2010
396
0.020
 Why?
Regression Analysis
1
2009
809
0.020
 Why?
Psychotic Disorders
1
2009
149
0.020
 Why?
Time Factors
1
2017
6545
0.020
 Why?
Follow-Up Studies
1
2014
5443
0.010
 Why?
Predictive Value of Tests
1
2010
2288
0.010
 Why?
Sex Factors
1
2009
1353
0.010
 Why?
Prevalence
1
2010
2634
0.010
 Why?
Anxiety
1
2009
1006
0.010
 Why?
Quality of Life
1
2010
2168
0.010
 Why?
Surveys and Questionnaires
1
2010
3988
0.010
 Why?
Prospective Studies
1
2009
6585
0.010
 Why?
Child, Preschool
1
2010
14874
0.010
 Why?
Adult
1
2009
31686
0.000
 Why?
SHERER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (93)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_